Neutrophil glucose flux as a therapeutic target in antiphospholipid syndrome is a research paper published in Journal of Clinical Investigation (2024). On theSindex it has a DataRank of 0. It has been cited 15 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph β no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full β never from an abstract alone.
Rheumatology Research Foundation
Grant: 882085
University of Michigan
Grant: T32HD007505
National Institutes of Health
Grant: R01AI097134
National Cancer Institute
Grant: R37CA23742
National Institutes of Health
Grant: R01HL134846
NIAMS NIH HHS
Grant: K08 AR080205
National Institutes of Health
Grant: 2T32HD007505-06
TRAINING PROGRAM IN ORGANOGENESIS
National Institutes of Health
Grant: 5K08AR080205-02
Thromboinflammatory consequences of infection-induced autoimmunity
National Institutes of Health
Grant: 5R01HL134846-04
Purinergic modulation of the autoimmune vascular phenotype
National Institutes of Health
Grant: 5R37AI023742-08
MOLECULAR BIOLOGY OF MULTIPARTITE GENOME VIRUSES
National Institutes of Health
Grant: 1R01AI097134-01A1
Role of DNA methylation in lupus
FWCI
2.34
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals